- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Latest News
- Contact us
Pharma Webinar: Handheld Raman – Cut costs, improve efficiency & move toward 100% testing
This pharma webinar was recorded on 27th September 2012:
In this pharma webinar you will learn how handheld Raman is being used to streamline the pharmaceutical manufacturing process and reduce pharmaceutical product recalls and plant shutdowns. We provide a brief overview of typical incoming raw material inspection processes and discuss how handheld Raman increases productivity and satisfies stringent cGMP requirements. We also discuss how recent developments in handheld Raman technology will continue to enable wider and faster deployment to achieve the goal of 100% testing of raw materials. Lastly, we discuss the importance of a simplified user interface for non-technical users and how advances in technology have addressed this need.
Ravi Kalyanaraman, PhD
Ravi Kalyanaraman is an Associate Director at Bristol-Myers Squibb Company in Global Analytical Technology group with Global Manufacturing and Supply. He received his Ph.D. from the University of Idaho in 1996 and has been with Bristol-Myers Squibb since 2002. His recent work with Bristol-Myers Squibb has been focused on developing new and novel techniques to detect pharmaceutical counterfeits and raw material authentication. His interests are mainly in using vibrational spectroscopic techniques, such as Raman, mid and Near-Infrared (NIR) for pharmaceutical counterfeit detection.
John Kauffman, Research Chemist, FDA
John leads a team of spectroscopists who develop portable spectroscopic methods for rapid screening of pharmaceutical materials using chemometric models. Spectroscopic technologies currently under investigation include x-ray fluorescence, ion mobility spectrometry, Raman and NIR spectroscopy. His team also performs research on process analytical technologies for pharmaceutical manufacturing. In addition he runs projects that utilise deep ultraviolet resonance Raman spectroscopy for analysis of therapeutic proteins, and inductively coupled plasma mass spectrometry for analysis of toxic metals in pharmaceuticals.
Enrique Lozano Diz PhD, Business Development Manager, B&W Tek
Enrique Lozano Diz is the Business Development Manager at B&W Tek. He is responsible for guiding product management and developing new strategic business partnerships, as well as supporting global partners. He has 8 years of extensive experience in spectroscopy and the instrumentation market, as well as a Ph.D. in Chemistry.